Skip to main content
×
Home
    • Aa
    • Aa

Person-centred medicines optimisation policy in England: an agenda for research on polypharmacy

  • Janet Heaton (a1), Nicky Britten (a2), Janet Krska (a3) and Joanne Reeve (a4)
Abstract
Aim

To examine how patient perspectives and person-centred care values have been represented in documents on medicines optimisation policy in England.

Background

There has been growing support in England for a policy of medicines optimisation as a response to the rise of problematic polypharmacy. Conceptually, medicines optimisation differs from the medicines management model of prescribing in being based around the patient rather than processes and systems. This critical examination of current official and independent policy documents questions how central the patient is in them and whether relevant evidence has been utilised in their development.

Methods

A documentary analysis of reports on medicines optimisation published by the Royal Pharmaceutical Society (RPS), The King’s Fund and National Institute for Health and Social Care Excellence since 2013. The analysis draws on a non-systematic review of research on patient experiences of using medicines.

Findings

The reports varied in their inclusion of patient perspectives and person-centred care values, and in the extent to which they drew on evidence from research on patients’ experiences of polypharmacy and medicines use. In the RPS report, medicines optimisation is represented as being a ‘step change’ from medicines management, in contrast to the other documents which suggest that it is facilitated by the systems and processes that comprise the latter model. Only The King’s Fund report considered evidence from qualitative studies of people’s use of medicines. However, these studies are not without their limitations.

We suggest five ways in which researchers could improve this evidence base and so inform the development of future policy: by facilitating reviews of existing research; conducting studies of patient experiences of polypharmacy and multimorbidity; evaluating medicines optimisation interventions; making better use of relevant theories, concepts and tools; and improving patient and public involvement in research and in guideline development.

Copyright
Corresponding author
Correspondence to: Dr Janet Heaton, Research Fellow, PenCLAHRC, University of Exeter Medical School, South Cloisters (Rm 1.36), St Luke’s Campus, Exeter EX1 2LU, Devon, UK. Email: j.heaton@exeter.ac.uk
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

N. Britten 2007: Understanding medicine taking in context. In J. Dowell, B. Williams and D. Snadden, editor. Patient-centered prescribing: seeking concordance in practice. Oxford: Radcliffe Publishing, 2943.

R.L. Bushardt , E.B. Massey , T.W. Simpson , J.C. Ariail and K.N. Simpson 2008: Polypharmacy: misleading, but manageable. Clinical Interventions in Aging 3, 383389.

S. Demain , A.-C. Gonçalves , C. Areia , R. Oliveira , J. Marcos , A. Marques , R. Parmar and K. Hunt 2015: Living with, managing and minimising treatment burden in long term conditions: a systematic review of qualitative research. PLOS One 10, 18pp.

M. Duerden , T. Avery and R. Payne 2013: Polypharmacy and medicines optimisation: making it safe and sound. London: King’s Fund. 56pp.

I. Ekman , K. Swedberg , C. Taft , A. Lindseth , A. Norberg , E. Brink , J. Carlsson , S. Dahlin-Ivanoff , I.-L. Johansson , K. Kjellgren , E. Lidén , J. Öhlén , L.-E. Olssen , H. Rosén , M. Rydmark and K.S. Sunnerhagen 2011: Person-centred care – ready for prime time. European Journal of Cardiovascular Nursing 10, 248251.

M. Krahn and G. Naglie 2008: The next step in guideline development: incorporating patient preferences. JAMA 300, 436438.

J. Krska , C.W. Morecroft , H. Poole and P.H. Rowe 2013: Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study. International Journal of Clinical Pharmacology 35, 11611169.

C.R. May , D.T. Eton , K. Boehmer , K. Gallacher , K. Hunt , S. MacDonald , F.S. Mair , C.M. May , V.M. Montori , A. Richardson , A.E. Rogers and N. Shippee 2014: Rethinking the patient: using burden of treatment theory to understand the changing dynamics of illness. BMC Health Services Research 14, 281.

V.M. Montori , J.P. Brito and M.H. Murad 2013: The optimal practice of evidence-based medicine: incorporating patient preferences in practice guidelines. JAMA 310, 25032504.

R.L Morris , C. Sanders , A.P. Kennedy and A. Rogers 2011: Shifting priorities in multimorbidity: a longitudinal study of patient’s prioritization of multiple conditions. Chronic Illness 7, 147161.

Royal Pharmaceutical Society (RPS) (nd) Medicines optimisation: the evidence in practice. Retrieved 14 October 2015 from www.rpharms.com/promoting-pharmacy-pdfs/mo---evidence-in-practice.pdf.

M. Skinner 2015: A literature review: polypharmacy protocol for primary care. Geriatric Nursing 36, 5pp.

M. Wilson , A. Mair , T. Dreischulte and M.D. Witham 2015: Prescribing to fit the needs of older people- the NHS Scotland Polypharmacy Guidance, 2nd edition. Journal Royal College Physicians 45, 108113.

P.M. Wilson , N. Kataria and E. McNeilly 2013: Patient and carer experience of obtaining regular prescribed medication for chronic disease in the English National Health Service: a qualitative study. BMC Health Services Research 13, 192. 11pp. doi: 10.1186/1472-6963-13-192.

A. Townsend , K. Hunt and S. Wyke 2003: Managing multiple morbidity in mid-life: A qualitative study of attitudes to drug use. British Medical Journal 327(837), 6pp.

A.L. Leppin , V.M. Montori and M.R. Gionfriddo 2015: Minimally disruptive medicine: a pragmatically comprehensive model for delivering care to patients with multiple chronic conditions. Healthcare 3, 5063.

J. Reeve , M. Dickenson , J. Harris , E. Ranson , U. Dohnhammer , L. Cooper , J. Krska , R. Byng and N. Britten 2015: Solutions to problematic polypharmacy: learning from the expertise of patients. British Journal of General Practice, doi:10.3399/bjgp15X685465.

R.J. Stack , R.A. Elliot , P.R. Noyce and C. Bundy 2008: A qualitative exploration of multiple medicines beliefs in co-morbid diabetes and cardiovascular disease. Diabetic Medicine 25, 7pp. doi: 10.1111/j.1464-5491.2008.02561.x.

A. Townsend , K. Hunt and S. Wyke 2003: Managing multiple morbidity in mid-life: A qualitative study of attitudes to drug use. British Medical Journal 327(837), 6pp.

A. Townsend , S. Wyke and K. Hunt 2006: Self-managing and managing self: Practical and moral dilemmas in accounts of living with chronic illness. Chronic Illness, 2, 185194.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Primary Health Care Research & Development
  • ISSN: 1463-4236
  • EISSN: 1477-1128
  • URL: /core/journals/primary-health-care-research-and-development
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 3
Total number of PDF views: 85 *
Loading metrics...

Abstract views

Total abstract views: 399 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 21st September 2017. This data will be updated every 24 hours.